This guidance replaces previous conditional recommendations for the use of these drugs and is based on emerging evidence that they’re not likely to work...
A variety of companies are working to develop small-scale modular systems. Sunflower Therapeutics says it is different because they are focused on recombinant...
Digital connectivity relies upon the use of intuitive and plug-and-play automation, coupled with standardized and simplified manufacturing execution systems....
Researchers at the University of Washington have discovered how to create peptide molecules that can slip through membranes to enter cells — and they’ve...
Researchers also dove into socio-economic disparities in cancer care. Last month in Chicago, Illinois the American Society of The post Checkpoint inhibitors,...
Weeks after evidence suggested current Omicron subvariants may be less susceptible to AstraZeneca’s prophylactic Covid-19 treatment Evusheld, the UK...
Nurses Describe 'Brutal' COVID-19 Treatment Protocols Authored by Matt McGregor via The Epoch Times (emphasis ours), Nurses who witnessed...
Weeks after evidence suggested current Omicron subvariants may be less susceptible to AstraZeneca’s prophylactic Covid-19 treatment Evusheld, the UK...
Pfizer CEO Albert Bourla Tests Positive For COVID-19 Authored by Zachary Stieber via The Epoch Times, Pfizer’s CEO has tested positive...
The top performers among drugs launched in 2020 were each the first of their kind.
Antibody-drug conjugates are coming back to the fore, with talks of multi-billion dollar buyouts and a rapidly growing The post Oncology market dominance:...
Face masks are still an effective way to help stop the spread of the BA.5 subvariant.
BIRMINGHAM, Ala. – The SARS-CoV-2 that causes COVID-19 has killed 6.3 million people worldwide since 2019, painfully highlighting the vulnerability of...
AstraZeneca’s prophylactic treatment for Covid-19, known as Evusheld, has survived where other mAbs failed, showing efficacy for the immunocompromised...
AstraZeneca’s prophylactic treatment for Covid-19, known as Evusheld, has survived where other mAbs failed, showing efficacy for the immunocompromised...
AstraZeneca’s prophylactic treatment for Covid-19, known as Evusheld, has survived where other mAbs failed, showing efficacy for the immunocompromised...
PHILADELPHIA — (July 7, 2022) — Under a Defense Advanced Research Projects Agency (DARPA) and Joint Program Executive Office for Chemical, Biological,...
Inflammatory disease drug developers would rather block a discrete step in a multistep inflammatory process—the equivalent of blocking a narrow mountain...
Army scientists and industry partners were among the first to demonstrate that messenger RNA (mRNA)—the technology recently used in COVID-19 vaccines...
*Click here to watch “The hunt for COVID-19 variants” video Credit: UT Southwestern Medical Center *Click here to watch “The hunt for COVID-19 variants”...
Innovation Pharmaceuticals Inc (OTCMKTS: IPIX) is moving steadily northbound with power after the Company reported Brilacidin, its defensin-mimetic drug...
Although the different SARS-CoV-2 variants currently in circulation are undoubtedly less severe in vaccinated individuals in the general population, immunocompromised...
In response to the global COVID-19 pandemic, vaccine research and manufacturing processes have seen unprecedented advancements over a short timeframe....
Biden Administration Sued Over Records On Withholding COVID-19 Treatment From Florida Authored by Zachary Stieber via The Epoch Times (emphasis...
Two broadly neutralizing antibodies show great promise to provide long-acting immunity against COVID-19 in immunocompromised populations according to a...
The COVID-19 pandemic has driven RNA into the public eye and there is increasing recognition of its importance in medicine. The intense scientific drive...
Nascent Biotech Inc (OTCMKTS: NBIO) is making a steady run northbound off its base at a nickel and saw some of its biggest gains while the...
Scientists discovered years ago that newborn infants depend upon immune components transferred from their mothers to survive the onslaught of pathogens...
AstraZeneca announced Wednesday that the results of the company's TACKLE Phase III trial of Evusheld (tixagevimab and cilgavimab, formerly AZD7442) for...
Use of Pfizer Inc.'s COVID-19 antiviral Paxlovid spiked this week, but some doctors are reconsidering the pills for lower-risk patients after a U.S. public...